Serum prostate-specific antigen levels in men with type 2 diabetes

被引:53
作者
Fiukui, Michiaki [1 ]
Tanaka, Muhei [1 ]
Kadono, Mayuko [1 ]
Imai, Saeko [2 ]
Hasegawa, Goji [1 ]
Yoshikawa, Toshikazu [1 ]
Nakamura, Naoto [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Endocrinol & Metab, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan
[2] Osaka Prefecture Univ, Fac Comprehens Rehabil, Dept Clin Nutr, Osaka, Japan
关键词
D O I
10.2337/dc07-1962
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The aims of this study were to examine if serum prostate-specific antigen (PSA) levels are lower in men with type 2 diabetes compared with those in healthy men and to investigate what factors may be associated with serum PSA levels in men with type 2 diabetes. RESEARCH DESIGN AND METHODS - We compared the serum PSA levels in 224 diabetic men with those in 1,293 healthy men and investigated the relationships between serum PSA levels and various variables. RESULTS - Except for men aged 40-49 years, serum PSA levels were lower in diabetic men than in healthy men. Multiple regression analysis demonstrated that age, BMI, and presence of diabetes were independent determinants of serum PSA level. CONCLUSIONS - Serum PSA levels were lower in diabetic men compared with those in healthy men, which is in line with previous reports that patients with type 2 diabetes are at a decreased risk of prostate cancer.
引用
收藏
页码:930 / 931
页数:2
相关论文
共 9 条
[1]   TESTOSTERONE CONCENTRATIONS IN WOMEN AND MEN WITH NIDDM [J].
ANDERSSON, B ;
VERMEULEN, A ;
MARIN, P ;
BJORNTORP, P ;
LISSNER, L .
DIABETES CARE, 1994, 17 (05) :405-411
[2]   Diabetes mellitus and risk of prostate cancer: a meta-analysis [J].
Bonovas, S ;
Filioussi, K ;
Tsantes, A .
DIABETOLOGIA, 2004, 47 (06) :1071-1078
[3]   DIABETES-MELLITUS AS A RISK FACTOR FOR PANCREATIC-CANCER - A METAANALYSIS [J].
EVERHART, J ;
WRIGHT, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (20) :1605-1609
[4]   PHYSIOLOGICAL VARIATIONS OF SERUM TESTOSTERONE WITHIN THE NORMAL RANGE DO NOT AFFECT SERUM PROSTATE-SPECIFIC ANTIGEN [J].
MONATH, JR ;
MCCULLOUGH, DL ;
HART, LJ ;
JAROW, JP .
UROLOGY, 1995, 46 (01) :58-61
[5]   Diabetes and risk of prostate cancer in a prospective cohort of US men [J].
Rodriguez, C ;
Patel, AV ;
Mondul, AM ;
Jacobs, EJ ;
Thun, MJ ;
Calle, EE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (02) :147-152
[6]   Hormonal predictors of prostate cancer: A meta-analysis [J].
Shaneyfelt, T ;
Husein, R ;
Bubley, G ;
Mantzoros, CS .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :847-853
[7]  
Strickler H D, 2001, Diabetes Technol Ther, V3, P263, DOI 10.1089/152091501300209633
[8]   Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications [J].
Velicer, C. M. ;
Dublin, S. ;
White, E. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2007, 10 (01) :46-51
[9]   Reduced risk of prostate cancer among patients with diabetes mellitus [J].
Weiderpass, E ;
Ye, WM ;
Vainio, H ;
Kaaks, R ;
Adami, HO .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (03) :258-261